215 results on '"Talleur, Aimee C."'
Search Results
2. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial
3. Latent human herpesvirus 6 is reactivated in CAR T cells
4. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults
5. EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy
6. INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities
7. Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells
8. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
9. Integration of Palliative Care in Hematopoietic Cell Transplant: Pediatric Patient and Parent Needs and Attitudes
10. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
11. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
12. Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study
13. Neuroimaging Findings during Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) - a CAR T Cell Neurotoxicity Imaging Virtual Archive (CARNIVAL) Study
14. Risk Factors for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia
15. Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease
16. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
17. Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience
18. Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation
19. Treatment patterns and disease outcomes for pediatric patients with refractory or recurrent Hodgkin lymphoma treated with curative-intent salvage radiotherapy
20. Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cells
21. CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
22. Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia
23. Integrome signatures of lentiviral gene therapy for SCID-X1 patients
24. INSPIRED Symposium Part 3: Prevention and Management of Pediatric CAR T Cell-Associated Emergent Toxicities
25. Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients
26. Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel
27. Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony–Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells
28. Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
29. Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
30. Supplementary Figure from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
31. Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control
32. A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms
33. Second Allogeneic HCT Can Successfully Salvage a Subset of Patients Who Relapse Following First Allogeneic HCT: A Single-Center Retrospective Analysis of 108 Pediatric Patients
34. Activity of CD19-CAR T Cell Therapy Against Extramedullary Disease in Pediatric Patients with B-ALL
35. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
36. Latent human herpesvirus 6 is reactivated in chimeric antigen receptor T cells
37. Chimeric Antigen Receptor T-cell Therapy
38. Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
39. Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
40. Bone mineral density (BMD) deficits in adult survivors of childhood cancer: Attributable risks and long-term consequences.
41. CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
42. Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T cell receptor lineages
43. Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy
44. CD45RA Depleted T-Cell Addback and Prophylactic Blinatumomab Administration Following Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia
45. Pediatric Patient and Caregiver Reported Symptom Burden, Anxiety, Depression, and Quality of Life during CD19-CAR T-Cell Therapy
46. CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies
47. Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML
48. Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells
49. Extracorporeal Membrane Oxygenation Candidacy in Pediatric Patients Treated With Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy: An International Survey
50. Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T cell receptor lineages
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.